A detailed history of Cibc Bancorp Usa Inc. transactions in Codexis, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 10,528 shares of CDXS stock, worth $18,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,528
Holding current value
$18,950
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$2.35 - $3.33 $24,740 - $35,058
10,528 New
10,528 $25,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $118M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Cibc Bancorp Usa Inc. Portfolio

Follow Cibc Bancorp Usa Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Bancorp Usa Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc Bancorp Usa Inc. with notifications on news.